🇺🇸 FDA
Patent

US 11040019

Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration

granted A61KA61K31/138A61K31/4535

Quick answer

US patent 11040019 (Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/138, A61K31/4535, A61K31/55, A61P